IBDEI080 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10496,1,3,0)
 ;;=3^Facial Scar
 ;;^UTILITY(U,$J,358.3,10496,1,4,0)
 ;;=4^709.2
 ;;^UTILITY(U,$J,358.3,10496,2)
 ;;=^108131
 ;;^UTILITY(U,$J,358.3,10497,0)
 ;;=710.0^^64^625^60
 ;;^UTILITY(U,$J,358.3,10497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10497,1,3,0)
 ;;=3^Lupus,Systemic Erythmatosis
 ;;^UTILITY(U,$J,358.3,10497,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,10497,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,10498,0)
 ;;=710.9^^64^625^10
 ;;^UTILITY(U,$J,358.3,10498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10498,1,3,0)
 ;;=3^Collagen Disease NOS
 ;;^UTILITY(U,$J,358.3,10498,1,4,0)
 ;;=4^710.9
 ;;^UTILITY(U,$J,358.3,10498,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,10499,0)
 ;;=714.0^^64^625^97
 ;;^UTILITY(U,$J,358.3,10499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10499,1,3,0)
 ;;=3^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,10499,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,10499,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,10500,0)
 ;;=714.30^^64^625^98
 ;;^UTILITY(U,$J,358.3,10500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10500,1,3,0)
 ;;=3^Rheumatoid Arthritis,Juvenile
 ;;^UTILITY(U,$J,358.3,10500,1,4,0)
 ;;=4^714.30
 ;;^UTILITY(U,$J,358.3,10500,2)
 ;;=^24424
 ;;^UTILITY(U,$J,358.3,10501,0)
 ;;=744.89^^64^625^38
 ;;^UTILITY(U,$J,358.3,10501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10501,1,3,0)
 ;;=3^Face/Neck Anom NEC,Congenital
 ;;^UTILITY(U,$J,358.3,10501,1,4,0)
 ;;=4^744.89
 ;;^UTILITY(U,$J,358.3,10501,2)
 ;;=^272875
 ;;^UTILITY(U,$J,358.3,10502,0)
 ;;=759.6^^64^625^115
 ;;^UTILITY(U,$J,358.3,10502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10502,1,3,0)
 ;;=3^Von-Hippel Lindau Disease
 ;;^UTILITY(U,$J,358.3,10502,1,4,0)
 ;;=4^759.6
 ;;^UTILITY(U,$J,358.3,10502,2)
 ;;=^87431
 ;;^UTILITY(U,$J,358.3,10503,0)
 ;;=759.82^^64^625^62
 ;;^UTILITY(U,$J,358.3,10503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10503,1,3,0)
 ;;=3^Marfan Syndrome
 ;;^UTILITY(U,$J,358.3,10503,1,4,0)
 ;;=4^759.82
 ;;^UTILITY(U,$J,358.3,10503,2)
 ;;=^74034
 ;;^UTILITY(U,$J,358.3,10504,0)
 ;;=802.4^^64^625^36
 ;;^UTILITY(U,$J,358.3,10504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10504,1,3,0)
 ;;=3^FX Malar/Maxillary Bones,Closed
 ;;^UTILITY(U,$J,358.3,10504,1,4,0)
 ;;=4^802.4
 ;;^UTILITY(U,$J,358.3,10504,2)
 ;;=^25312
 ;;^UTILITY(U,$J,358.3,10505,0)
 ;;=870.1^^64^625^53
 ;;^UTILITY(U,$J,358.3,10505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10505,1,3,0)
 ;;=3^Laceration Full Thickness
 ;;^UTILITY(U,$J,358.3,10505,1,4,0)
 ;;=4^870.1
 ;;^UTILITY(U,$J,358.3,10505,2)
 ;;=^274880
 ;;^UTILITY(U,$J,358.3,10506,0)
 ;;=870.2^^64^625^34
 ;;^UTILITY(U,$J,358.3,10506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10506,1,3,0)
 ;;=3^Eyelid Laceration Involving Lacrimal
 ;;^UTILITY(U,$J,358.3,10506,1,4,0)
 ;;=4^870.2
 ;;^UTILITY(U,$J,358.3,10506,2)
 ;;=^274881
 ;;^UTILITY(U,$J,358.3,10507,0)
 ;;=870.3^^64^625^83
 ;;^UTILITY(U,$J,358.3,10507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10507,1,3,0)
 ;;=3^Orbital Wound,Penetrating
 ;;^UTILITY(U,$J,358.3,10507,1,4,0)
 ;;=4^870.3
 ;;^UTILITY(U,$J,358.3,10507,2)
 ;;=^274882
 ;;^UTILITY(U,$J,358.3,10508,0)
 ;;=870.9^^64^625^69
 ;;^UTILITY(U,$J,358.3,10508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10508,1,3,0)
 ;;=3^Ocular Adnexa Open Wound,Unspec
 ;;^UTILITY(U,$J,358.3,10508,1,4,0)
 ;;=4^870.9
 ;;^UTILITY(U,$J,358.3,10508,2)
 ;;=^274885
 ;;^UTILITY(U,$J,358.3,10509,0)
 ;;=871.0^^64^625^70
 ;;^UTILITY(U,$J,358.3,10509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10509,1,3,0)
 ;;=3^Ocular Laceration
 ;;^UTILITY(U,$J,358.3,10509,1,4,0)
 ;;=4^871.0
 ;;^UTILITY(U,$J,358.3,10509,2)
 ;;=^274886
 ;;^UTILITY(U,$J,358.3,10510,0)
 ;;=871.1^^64^625^71
 ;;^UTILITY(U,$J,358.3,10510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10510,1,3,0)
 ;;=3^Ocular Laceration w/ Prolapse
 ;;^UTILITY(U,$J,358.3,10510,1,4,0)
 ;;=4^871.1
 ;;^UTILITY(U,$J,358.3,10510,2)
 ;;=^274887
 ;;^UTILITY(U,$J,358.3,10511,0)
 ;;=871.2^^64^625^99
 ;;^UTILITY(U,$J,358.3,10511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10511,1,3,0)
 ;;=3^Rupture Eye,Trauma Enuc
 ;;^UTILITY(U,$J,358.3,10511,1,4,0)
 ;;=4^871.2
 ;;^UTILITY(U,$J,358.3,10511,2)
 ;;=^274888
 ;;^UTILITY(U,$J,358.3,10512,0)
 ;;=871.6^^64^625^59
 ;;^UTILITY(U,$J,358.3,10512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10512,1,3,0)
 ;;=3^Lens,Penetration w/ FB
 ;;^UTILITY(U,$J,358.3,10512,1,4,0)
 ;;=4^871.6
 ;;^UTILITY(U,$J,358.3,10512,2)
 ;;=^274891
 ;;^UTILITY(U,$J,358.3,10513,0)
 ;;=871.7^^64^625^72
 ;;^UTILITY(U,$J,358.3,10513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10513,1,3,0)
 ;;=3^Ocular Penetration,Unspec
 ;;^UTILITY(U,$J,358.3,10513,1,4,0)
 ;;=4^871.7
 ;;^UTILITY(U,$J,358.3,10513,2)
 ;;=^274892
 ;;^UTILITY(U,$J,358.3,10514,0)
 ;;=871.9^^64^625^9
 ;;^UTILITY(U,$J,358.3,10514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10514,1,3,0)
 ;;=3^Ciliary Body,Open Wound
 ;;^UTILITY(U,$J,358.3,10514,1,4,0)
 ;;=4^871.9
 ;;^UTILITY(U,$J,358.3,10514,2)
 ;;=^274893
 ;;^UTILITY(U,$J,358.3,10515,0)
 ;;=907.2^^64^625^56
 ;;^UTILITY(U,$J,358.3,10515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10515,1,3,0)
 ;;=3^Late Eff Spinal Cord Injury
 ;;^UTILITY(U,$J,358.3,10515,1,4,0)
 ;;=4^907.2
 ;;^UTILITY(U,$J,358.3,10515,2)
 ;;=^275240
 ;;^UTILITY(U,$J,358.3,10516,0)
 ;;=909.5^^64^625^57
 ;;^UTILITY(U,$J,358.3,10516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10516,1,3,0)
 ;;=3^Late or Adverse Effect of Drug
 ;;^UTILITY(U,$J,358.3,10516,1,4,0)
 ;;=4^909.5
 ;;^UTILITY(U,$J,358.3,10516,2)
 ;;=^303353
 ;;^UTILITY(U,$J,358.3,10517,0)
 ;;=918.0^^64^625^104
 ;;^UTILITY(U,$J,358.3,10517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10517,1,3,0)
 ;;=3^Superfic Inj,Eyelids/Periocular
 ;;^UTILITY(U,$J,358.3,10517,1,4,0)
 ;;=4^918.0
 ;;^UTILITY(U,$J,358.3,10517,2)
 ;;=^275352
 ;;^UTILITY(U,$J,358.3,10518,0)
 ;;=918.2^^64^625^103
 ;;^UTILITY(U,$J,358.3,10518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10518,1,3,0)
 ;;=3^Superfic Inj,Conjunctiva
 ;;^UTILITY(U,$J,358.3,10518,1,4,0)
 ;;=4^918.2
 ;;^UTILITY(U,$J,358.3,10518,2)
 ;;=^275353
 ;;^UTILITY(U,$J,358.3,10519,0)
 ;;=921.3^^64^625^111
 ;;^UTILITY(U,$J,358.3,10519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10519,1,3,0)
 ;;=3^Traumatic Hyphemia
 ;;^UTILITY(U,$J,358.3,10519,1,4,0)
 ;;=4^921.3
 ;;^UTILITY(U,$J,358.3,10519,2)
 ;;=^275369
 ;;^UTILITY(U,$J,358.3,10520,0)
 ;;=930.1^^64^625^14
 ;;^UTILITY(U,$J,358.3,10520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10520,1,3,0)
 ;;=3^Conjunctival Sac,Foreign Body
 ;;^UTILITY(U,$J,358.3,10520,1,4,0)
 ;;=4^930.1
 ;;^UTILITY(U,$J,358.3,10520,2)
 ;;=^275486
 ;;^UTILITY(U,$J,358.3,10521,0)
 ;;=930.8^^64^625^33
 ;;^UTILITY(U,$J,358.3,10521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10521,1,3,0)
 ;;=3^Eye,Oth/Combined Sites,Foreign Body
 ;;^UTILITY(U,$J,358.3,10521,1,4,0)
 ;;=4^930.8
 ;;^UTILITY(U,$J,358.3,10521,2)
 ;;=^275488
 ;;^UTILITY(U,$J,358.3,10522,0)
 ;;=940.0^^64^625^8
 ;;^UTILITY(U,$J,358.3,10522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10522,1,3,0)
 ;;=3^Chemical Burn,Periocular
 ;;^UTILITY(U,$J,358.3,10522,1,4,0)
 ;;=4^940.0
 ;;^UTILITY(U,$J,358.3,10522,2)
 ;;=^275512
 ;;^UTILITY(U,$J,358.3,10523,0)
 ;;=940.1^^64^625^35
 ;;^UTILITY(U,$J,358.3,10523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10523,1,3,0)
 ;;=3^Eyelid,Burns
 ;;^UTILITY(U,$J,358.3,10523,1,4,0)
 ;;=4^940.1
 ;;^UTILITY(U,$J,358.3,10523,2)
 ;;=^275513
 ;;^UTILITY(U,$J,358.3,10524,0)
 ;;=940.2^^64^625^18
 ;;^UTILITY(U,$J,358.3,10524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10524,1,3,0)
 ;;=3^Cornea/Conj,Alkaline Burn
 ;;^UTILITY(U,$J,358.3,10524,1,4,0)
 ;;=4^940.2
 ;;^UTILITY(U,$J,358.3,10524,2)
 ;;=^275514
 ;;^UTILITY(U,$J,358.3,10525,0)
 ;;=940.3^^64^625^17
 ;;^UTILITY(U,$J,358.3,10525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10525,1,3,0)
 ;;=3^Cornea/Conj,Acid Burn
 ;;^UTILITY(U,$J,358.3,10525,1,4,0)
 ;;=4^940.3
 ;;^UTILITY(U,$J,358.3,10525,2)
 ;;=^275515
 ;;^UTILITY(U,$J,358.3,10526,0)
 ;;=940.4^^64^625^19
 ;;^UTILITY(U,$J,358.3,10526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10526,1,3,0)
 ;;=3^Cornea/Conj,Oth Burn
 ;;^UTILITY(U,$J,358.3,10526,1,4,0)
 ;;=4^940.4
 ;;^UTILITY(U,$J,358.3,10526,2)
 ;;=^275516
 ;;^UTILITY(U,$J,358.3,10527,0)
 ;;=941.12^^64^625^31
 ;;^UTILITY(U,$J,358.3,10527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10527,1,3,0)
 ;;=3^Eye Erythema
 ;;^UTILITY(U,$J,358.3,10527,1,4,0)
 ;;=4^941.12
 ;;^UTILITY(U,$J,358.3,10527,2)
 ;;=^275531
 ;;^UTILITY(U,$J,358.3,10528,0)
 ;;=977.8^^64^625^4
 ;;^UTILITY(U,$J,358.3,10528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10528,1,3,0)
 ;;=3^Allergy to Fluorescein
 ;;^UTILITY(U,$J,358.3,10528,1,4,0)
 ;;=4^977.8
 ;;^UTILITY(U,$J,358.3,10528,2)
 ;;=^276154
 ;;^UTILITY(U,$J,358.3,10529,0)
 ;;=989.83^^64^625^110
 ;;^UTILITY(U,$J,358.3,10529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10529,1,3,0)
 ;;=3^Toxic Effect of Silicone
 ;;^UTILITY(U,$J,358.3,10529,1,4,0)
 ;;=4^989.83
 ;;^UTILITY(U,$J,358.3,10529,2)
 ;;=^303356
 ;;^UTILITY(U,$J,358.3,10530,0)
 ;;=995.29^^64^625^3
 ;;^UTILITY(U,$J,358.3,10530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10530,1,3,0)
 ;;=3^Adverse Effect of Drug
 ;;^UTILITY(U,$J,358.3,10530,1,4,0)
 ;;=4^995.29
 ;;^UTILITY(U,$J,358.3,10530,2)
 ;;=^334181
 ;;^UTILITY(U,$J,358.3,10531,0)
 ;;=998.30^^64^625^25
 ;;^UTILITY(U,$J,358.3,10531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10531,1,3,0)
 ;;=3^Disruption OP Wound
 ;;^UTILITY(U,$J,358.3,10531,1,4,0)
 ;;=4^998.30
 ;;^UTILITY(U,$J,358.3,10531,2)
 ;;=^336767
 ;;^UTILITY(U,$J,358.3,10532,0)
 ;;=998.31^^64^625^27
 ;;^UTILITY(U,$J,358.3,10532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10532,1,3,0)
 ;;=3^Disruption of Internal OP Wound
 ;;^UTILITY(U,$J,358.3,10532,1,4,0)
 ;;=4^998.31
 ;;^UTILITY(U,$J,358.3,10532,2)
 ;;=^336843
 ;;^UTILITY(U,$J,358.3,10533,0)
 ;;=998.32^^64^625^26
 ;;^UTILITY(U,$J,358.3,10533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10533,1,3,0)
 ;;=3^Disruption of External OP Wound
